“I am thrilled to join the Galt family and contribute to its mission of delivering accessible healthcare products through a robust franchise network.”

— Mike Harley

 

Beyond franchising, Mike has guided strategic growth and development across multiple industries, including travel, parking, retail, e-commerce, digital marketing, and other B2C verticals. His ability to boost revenue, profitability, and operational efficiency has made him a sought-after visionary strategist for franchise brands looking to scale.

At GPS, Mike will spearhead Galt’s franchise expansion efforts, ensuring that Galt Pharmaceuticals’ FDA-approved products reach a broader audience through a well-planned and sustainable growth model. His dynamic, hands-on leadership and forward-thinking vision will be instrumental in shaping GPS’s future as the first-ever pharmaceutical franchise model.

“I am thrilled to join the Galt family and contribute to its mission of delivering accessible healthcare products through a robust franchise network,” said Harley. “Franchising is a powerful tool for growth, and I look forward to leveraging my experience to support franchisees and elevate the brand’s success.”

About Galt Phranchise Systems
Based in Atlanta, GA, Galt Phranchise Systems (GPS) is the first and only franchisor to partner with a pharmaceutical company to create a unique franchise concept that allows an entrepreneur or business entity to market and promote pharmaceutical and health-related products in their local markets. With Galt Pharmaceuticals (www.galtrx.com) managing the high-barrier industry functions, Galt Phranchise Systems has worked hard in building the foundation and business systems that allow Phranchise Owners to focus on operating their truly patient-centric, local businesses. With over 500 territories available across the nation, GPS seeks entrepreneurial-minded sales or healthcare professionals looking to disrupt the big pharma model by decentralizing pharmaceutical sales and distribution.

Tucker Bedingfield
Galt Companies
+1 855-965-2783
email us here
Visit us on social media:
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.